Avitech and Fox Chase collaborate on gene tests:
This article was originally published in Clinica
Executive Summary
Avitech Diagnostics and the Fox Chase Cancer Center in Philadelphia are collaborating on the development of cancer tests. The two organisations will attempt to use CEL-1, an enzyme discovered at Fox Chase, to develop tests for mutations in the breast cancer genes, BRCA1 & 2; the tumour suppressor, p53; and the hereditary colon cancer gene, msh2.